Calling the deal announced late last year an alarming sign for biopharma, the US Federal Trade Commission (FTC) is seeking to block the closing of Amgen’s proposed $28...
In an as yet unusual move for a chemical producer, Dow plans to build what it said is a “first set” of small modular nuclear reactors at its Seadrift, Texas, site south...
US private equity group Apollo Management Holdings has walked away from a potential deal with Wood Group after more than four months of pursuing the British multinational...
Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion...
Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...
17.05.2023
- New buzzwords such as polycrisis and permacrisis are increasingly circulating, highlighting that we have grown accustomed to facing multiple crises since the 2000s, including 9/11...
The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine...
